COMMUNIQUÉS West-GlobeNewswire

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

04/04/2024 - 22:05

ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2024 - 22:05

WALTHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant date of April 1, [...]

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

04/04/2024 - 22:05

BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer [...]

Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call

04/04/2024 - 22:05

BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today [...]

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

04/04/2024 - 22:04

SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]

Optinose to Present at the Needham Virtual Healthcare Conference

04/04/2024 - 22:01

YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

04/04/2024 - 22:01

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 23 rd Annual [...]

Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million

04/04/2024 - 22:01

PEMGARDA now commercially available in the U.S. for pre-exposure prophylaxis (PrEP) of COVID-19 in certain adults and adolescents with moderate-to-severe immune compromise Based on anticipated net product revenue and [...]

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

04/04/2024 - 22:01

Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen, Belgium; 4 [...]

Immunocore to present at upcoming investor conferences

04/04/2024 - 22:00

Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 04 April 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a [...]

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/04/2024 - 22:00

WALTHAM, Mass. and DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein [...]

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

04/04/2024 - 19:44

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 8,733,626 shares of its [...]

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

04/04/2024 - 19:00

New method of use patent covers key aspects of the technology that enable patients to receive treatment from the privacy of their own homes HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “ [...]

Declaration of voting rights - Valneva SE, March 2024

04/04/2024 - 18:00

VALNEVA Declaration of shares and voting rights March 31, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]

Déclaration d'actions et de droits de vote de la société Valneva SE - mars 2024

04/04/2024 - 18:00

VALNEVA Déclaration d’actions et de droits de vote 31 mars 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]

H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities

04/04/2024 - 18:00

Born from H1’s 2023 initiative to recruit and deploy doctors to the Middle East, the platform connects doctors to NGOs for medical missions worldwide NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- H1 , the leading [...]

Appointment of Stephen M. Deitsch as new Chief Financial Officer

04/04/2024 - 17:43

OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx , a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking normothermic machine [...]

BioSig Engages Consulting Firm for Business Model Strategies

04/04/2024 - 17:35

BAIPC will work to deploy a series of solutions to transform BioSig’s future course Westport, CT, April 04, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical [...]

Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting

04/04/2024 - 17:30

New York, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (Lirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the upcoming [...]